Con­duct­ing tri­als via rou­tine clin­i­cal prac­tice: FDA ex­plains how in new draft guid­ance

The FDA on Tues­day firmed up its po­si­tion that in some lim­it­ed cir­cum­stances, clin­i­cal tri­al da­ta may be ob­tained from rou­tine clin­i­cal prac­tice. The use …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER